BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) ...

Patients who have been treated for heart failure and experience an improvement in their pump function are still at higher ...

China: A recent study highlights the potential risks associated with sarcopenic obesity (SO) in diabetic patients with heart ...

Inter-atrial shunt device therapy has shown mixed results in clinical trials, with clinical 'non-responders' typically showing features of more advanced heart failure. We aimed to analyse the ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher ...

Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently ...

Bayer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its kidney-disease drug Kerendia in certain people with heart failure.

Eosinophil Levels may predict prognosis in critically ill patients with HFrEF suggests a study published in the Scientific Reports.Heart failure (HF) is associated with poor prognosis.

Does finerenone improve outcomes in patients withheart failure (HF) with mildly reduced or preserved ejection fraction?

Cytokinetics is now rapidly moving into commercialization efforts with Aficamten. Read more to see why I rate CYTK stock a ...